6505--770-24-4-801-0686 -National CMOP CLINDAMYCIN -(VA-24-00096153)
ID: 36C77024Q0380Type: Presolicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Set Aside

Total Small Business Set-Aside (FAR 19.5) (SBA)

Original Source

https://sam.gov/opp/2081bdb14d9b42e995f36e37c1cfcccf/view
Timeline
    Description

    The Department of Veterans Affairs is seeking qualified vendors to provide Clindamycin PO4 1% Top Swab for delivery to multiple Compounding Medication Outpatient Pharmacies (CMOP) across the country. This procurement aims to secure approximately 3,584 units of the specified pharmaceutical product, ensuring compliance with federal regulations and the Drug Supply Chain Security Act (DSCSA). The goods are essential for the VA's healthcare services, supporting the treatment of various medical conditions. Interested vendors must submit their quotations by September 6, 2024, including a signed SF1449 cover page, a price schedule, proof of a valid State Wholesale Distributor License, and a Buy American Act Certificate. For further inquiries, vendors can contact Kelley Cunningham at kelley.cunningham@va.gov or call 913-684-0140.

    Point(s) of Contact
    Kelley CunninghamContact Specialist
    (913) 684-0140
    kelley.cunningham@va.gov
    Files
    Title
    Posted
    36C77024Q0380_1.docx
    The document outlines a government procurement solicitation by the Department of Veterans Affairs for pharmaceutical supplies targeting the National Consolidated Mail Outpatient Pharmacy (CMOP). It includes critical details such as solicitation number (36C77024Q0380), award details, and submission requirements for vendors. Key components consist of required deliverables (six line items of chemicals), specific shipping terms, compliance with strict barcoding standards, and the need for all products to be ship-compatible with USPS. Vendors must provide details like valid National Drug Codes (NDCs) for each product and adhere to the terms stated in the FAR and VAAR clauses. Additional requirements include a firm commitment regarding product availability, return provisions for nonconforming products, and completion of certain certifications related to the Drug Supply Chain Security Act. Invoicing instructions specify electronic submission facilitated by the VA's payment systems, ensuring timely processing. The purpose is to ensure the procurement of compliant and quality pharmaceutical products for the VA while fostering participation from small businesses and adhering to federal regulations and standards. This RFP reflects a structured approach to managing healthcare contracts efficiently, emphasizing both legal compliance and operational requirements.
    36C77024Q0380.docx
    The Department of Veterans Affairs (VA) plans to solicit bids for procuring Clindamycin PO4 1% Top Swab for delivery to multiple Compounding Medication Outpatient Pharmacies (CMOP) across the country. This presolicitation notice outlines the requirements for the solicitation number 36C77024Q0380, which is set aside for small businesses. The contract includes detailed quantities and packaging needs for multiple CMOP facilities, specifying a total of approximately 3,584 units across six locations. The estimated issue date for the request for quotation (RFQ) is September 3, 2024, with responses due by September 6, 2024. Vendors must submit quotations via email, including essential documentation such as a signed solicitation cover page (SF1449), a price schedule, a valid state wholesale distributor license, and a Buy American Act Certificate, verifying compliance with drug supply regulations. The document emphasizes that all responsible sources may submit a quotation, further encouraging transparency and competition among small businesses in the pharmaceutical sector. Compliance with the Drug Supply Chain Security Act (DSCSA) is mandatory for bidders.
    S02_Pricing Schedule_Q0380.xlsx
    The CMOP National RFQ 36C77024Q0380 is a solicitation for vendors to provide specific pharmaceutical and medical surgical supplies, with bids due by September 6, 2024, at 3:00 PM CT. Vendors must submit a signed SF1449 cover page, a quote spreadsheet, proof of a valid State Wholesale Distributor License, and a Buy American Act certificate. Each vendor can submit only one quote and must note any discrepancies between proposed and listed National Drug Codes (NDC) in the "Vendor Comments" section. Critical to this request is the stipulation that all products must have at least one year until expiration at the time of delivery. The document outlines various line items with specific requirements, including product descriptions, quantities, and pricing for items like Clindamycin Po4 1% Top Swab. The receipt of quotes is directed to a specific email address for further processing. This RFQ exemplifies a structured procurement process aimed at acquiring necessary medical supplies while ensuring compliance with federal regulations and guidelines.
    Similar Opportunities
    6505--770_Pharmaceuticals_VA CMOP National Office_36C77025Q0196 770-25-3-801-0371 -National CMOP A1222 ACAMPROSATE TAB
    Buyer not available
    The Department of Veterans Affairs is seeking vendors to provide Acamprosate Calcium 333mg EC tablets under solicitation number 36C77025Q0196 for delivery to multiple Consolidated Mail Outpatient Pharmacy (CMOP) facilities. The procurement includes specific quantities of the pharmaceutical product, with a total of six different delivery requirements outlined, emphasizing compliance with the Drug Supply Chain Security Act (DSCSA) and adherence to federal regulations regarding labeling and barcoding standards. This initiative is crucial for ensuring the timely and safe distribution of essential medications to veterans' healthcare facilities, reflecting the VA's commitment to quality healthcare services. Interested vendors must submit their quotes, including a signed Standard Form 1449, a detailed price schedule in Excel format, and a state wholesale distributor license by April 9, 2025, with the estimated award date set for April 14, 2025. For further inquiries, vendors can contact Michael W. McAlhaney at Michael.McAlhaney@va.gov or by phone at (913) 684-0134.
    6505--National CMOP ARTIFICIAL SALIVA ORAL SPRAY -(A2112) NDC 50930-0098-08
    Buyer not available
    The Department of Veterans Affairs, specifically the Network 15 CMOP Contracting Office, is seeking to procure Artificial Saliva Oral Spray (NDC 50930-0098-08) to replenish stock at multiple CMOP locations, with a total requirement of 11,752 bottles. This procurement is crucial for ensuring that veterans have access to essential health products, adhering to the Drug Supply Chain Security Act, which mandates the provision of pedigree information for all pharmaceuticals. Interested vendors must submit their quotations electronically to the contracting officer, Larry Zaritz, by May 22, 2025, at 11:00 AM Central Time, with the solicitation package expected to be available on SAM.gov around May 19, 2025.
    6505--Clobetasol Cream and Ointment (VA-25-00041429)
    Buyer not available
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) 36E79725R0040 for the unrestricted procurement of Clobetasol Propionate 0.05% Cream and Ointment. This procurement aims to supply the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC) with essential pharmaceutical products, divided into two groups: Group I for Cream and Group II for Ointment, each with specified package sizes and estimated annual usage. The contract will have a duration of one year, with the possibility of four additional one-year option periods, and requires offerors to provide unique National Drug Code (NDC) numbers and comply with specific packaging standards. Interested parties should monitor SAM.gov for updates, as the solicitation is set for electronic release around May 22, 2025, with a closing date of June 5, 2025; inquiries can be directed to Contract Specialist Ray Roldan at raymond.roldan@va.gov.
    770-25-3-801-0438 -National CMOP F0608: FERROUS SULFATE 324MG EC TAB
    Buyer not available
    The Department of Veterans Affairs is seeking vendors to provide Ferrous Sulfate 324mg EC tablets for its Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0233. Interested parties must submit a quotation that includes a signed SF1449 cover page, a detailed pricing schedule in Excel format, and relevant certifications, ensuring compliance with the Trade Agreements Act and federal regulations. This procurement is crucial for maintaining the supply of essential pharmaceutical products to VA facilities nationwide, supporting the healthcare needs of veterans. Quotes are due by May 22, 2024, at 4:00 PM CST, and vendors can contact Sarah Fry at sarah.fry2@va.gov or 913-758-9935 for further information.
    6505--Clonidine Patches
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for the procurement of clonidine patches, a pharmaceutical product essential for managing hypertension and attention deficit hyperactivity disorder (ADHD) in patients. Offerors are required to provide pricing for both base and option years, ensuring compliance with federal regulations such as the Drug Supply Chain Security Act (DSCSA), along with specific labeling and manufacturing requirements. This procurement aims to secure a consistent supply of pharmaceuticals at committed pricing for the VA and Department of Defense healthcare systems, emphasizing quality standards and traceability in the supply chain. Interested parties should contact Contract Specialist Christopher Carthron at Christopher.Carthron@va.gov for further details regarding submission requirements and deadlines.
    6505--Colchicine Tablets
    Buyer not available
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for Request for Proposal (RFP) 36E79725R0034 to procure Colchicine 0.6MG Tablets, aimed at ensuring a continuous supply of this medication for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). The contract will be for one year with four additional one-year option periods, requiring bidders to provide a unique National Drug Code (NDC) number and prohibiting any modifications to existing product labels. This procurement is critical for maintaining the availability of Colchicine, which is essential for treating various medical conditions. Interested parties should note that the solicitation will be electronically issued around May 9, 2025, with responses due by May 27, 2025; for inquiries, contact Richard Mahario at Richard.Mahario@va.gov or 708-786-5247.
    760-25-1-050-0154 -Leavenworth CMOP THYROID TABLETS -(VA-25-00022614)
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for the procurement of Armour Thyroid tablets for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0079. This Request for Quotation (RFQ) emphasizes the need for specific brand-name pharmaceuticals, with a focus on compliance with federal regulations, including the Drug Supply Chain Security Act and the Buy American Act. The procurement process aims to ensure a reliable supply of essential medications for veterans, with a firm-fixed-price contract expected to be awarded based on fair market evaluations. Interested vendors must submit their quotes by December 27, 2024, at 4:00 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.
    6505--Ibuprofen Tablets
    Buyer not available
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Ibuprofen Tablets, aimed at ensuring a continuous supply for various VA facilities, including Consolidated Mail Order Pharmacies, State Veterans Homes, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. This unrestricted procurement will result in a contract that spans one year, with the possibility of four additional one-year option periods, emphasizing the VA's commitment to providing essential pharmaceuticals to veterans and eligible entities. Interested offerors must provide specific branding information and a unique National Drug Code (NDC) for their products, with the solicitation expected to be released electronically around June 3, 2025, and proposals due by June 17, 2025. For further inquiries, interested parties should contact Contract Specialist Teresa Hussain at teresa.hussain@va.gov or by phone at 708-786-5852, noting that no paper copies of the solicitation will be available.
    6515--XI888: SYRINGE,FEEDING ENFIT 60ML (VA-25-00056417)
    Buyer not available
    The Department of Veterans Affairs is seeking qualified vendors to provide 60ml ENFIT feeding syringes for the National CMOP Office under solicitation number VA-25-00056417. Interested vendors must submit a signed solicitation cover page, a quote in Excel format, OEM authorization documentation, and a Trade Agreement Act (TAA) Certificate by May 21, 2025. This procurement is critical for ensuring the availability of high-quality medical supplies for VA Medical Centers, with strict guidelines in place to prevent the acceptance of products manufactured in China and to avoid gray market items. For further inquiries, vendors can contact Contract Specialist Kelley Cunningham at kelley.cunningham@va.gov.
    6515--Medical Surgical Prime Vendor (MSPV) Supplies Line-Item Detail Cleanup
    Buyer not available
    The Department of Veterans Affairs (VA) is conducting market research for the Medical Surgical Prime Vendor (MSPV) Supplies Line-Item Detail Cleanup, aimed at confirming item details for potential inclusion in the MSPV Supplies Program. This initiative is crucial for supporting the healthcare needs of approximately 9 million enrolled veterans through the VA’s extensive healthcare system, which includes 1,234 facilities nationwide. Interested vendors, particularly Original Equipment Manufacturers (OEM) and authorized suppliers, are required to complete the attached document and submit their responses via email by June 6, 2025. A virtual Industry Day will be held on May 21, 2025, to facilitate further engagement, and all inquiries should be directed to Jeremy Parker and Damon Ware at the provided email addresses.